Workflow
AMC(AMC) - 2024 Q4 - Annual Report
AMCAMC(AMC)2025-02-25 23:50

Financial Performance - Total revenues for the year ended December 31, 2024, were 4,637.2million,adecreaseof3.64,637.2 million, a decrease of 3.6% compared to 4,812.6 million in 2023 [459]. - Net loss for the year ended December 31, 2024, was 352.6million,animprovementfromanetlossof352.6 million, an improvement from a net loss of 396.6 million in 2023 [461]. - Admissions revenue decreased to 2,560.5millionin2024from2,560.5 million in 2024 from 2,690.5 million in 2023, reflecting a decline of 4.8% [459]. - Food and beverage revenue also saw a decline, totaling 1,624.9millionin2024comparedto1,624.9 million in 2024 compared to 1,669.8 million in 2023, a decrease of 2.7% [459]. - Operating loss for 2024 was 79.3million,slightlyworsethantheoperatinglossof79.3 million, slightly worse than the operating loss of 74.3 million in 2023 [459]. - Cash and cash equivalents decreased to 632.3millionasofDecember31,2024,downfrom632.3 million as of December 31, 2024, down from 884.3 million in 2023 [464]. - Total assets decreased to 8,247.5millionin2024from8,247.5 million in 2024 from 9,009.2 million in 2023, a decline of 8.4% [464]. - Total liabilities decreased to 10,008.0millionin2024from10,008.0 million in 2024 from 10,857.1 million in 2023, a reduction of 7.8% [464]. - Net cash used in operating activities improved to 50.8millionin2024from50.8 million in 2024 from 215.2 million in 2023 [466]. - The company reported a net cash decrease of 230.6millionfortheperiod,comparedtoanincreaseof230.6 million for the period, compared to an increase of 257.0 million in the previous period [467]. Debt and Financing - The company has an aggregate principal balance of 2,014.2millionoutstandingunderNewTermLoans,withinterestratesrangingfrom11.3562,014.2 million outstanding under New Term Loans, with interest rates ranging from 11.356% per annum [420]. - A 100-basis point increase in market interest rates would increase interest expense on New Term Loans by approximately 20.1 million for the year ended December 31, 2024 [421]. - The company had an aggregate principal balance of 1,905.0millionoutstandingunderExistingTermLoansasofDecember31,2023[424].A100basispointchangeinmarketinterestrateswouldhaveincreasedordecreasedinterestexpenseonExistingTermLoansby1,905.0 million outstanding under Existing Term Loans as of December 31, 2023 [424]. - A 100-basis point change in market interest rates would have increased or decreased interest expense on Existing Term Loans by 19.1 million during the year ended December 31, 2023 [424]. - The company anticipates potential dilution of Common Stock due to future share issuances related to debt repayment and refinancing [15]. - The company plans to continue seeking to retire or purchase outstanding debt through cash purchases and/or exchanges for equity or debt [479]. - The company issued 414.4millioninnewExchangeableNotesonJuly22,2024,withafairvalueofthederivativeliabilityassociatedwiththeembeddedconversionfeatureat414.4 million in new Exchangeable Notes on July 22, 2024, with a fair value of the derivative liability associated with the embedded conversion feature at 233.4 million [444]. - The Exchangeable Notes have an effective interest rate of 15.12%, with recorded interest expense of 18.2millionfortheperiodfromJuly22,2024,toDecember31,2024[593].TheNewTermLoansmatureonJanuary4,2029,unlesscertainconditionsregardingtheExistingFirstLienNotesaremet,whichcouldchangethematuritydatetoOctober5,2028[595].ThecompanycompletedrefinancingtransactionsonJuly22,2024,extendingthematuritiesofapproximately18.2 million for the period from July 22, 2024, to December 31, 2024 [593]. - The New Term Loans mature on January 4, 2029, unless certain conditions regarding the Existing First Lien Notes are met, which could change the maturity date to October 5, 2028 [595]. - The company completed refinancing transactions on July 22, 2024, extending the maturities of approximately 1.6 billion of debt previously maturing in 2026 to 2029 and 2030 [577]. Impairment and Asset Management - The company reported an impairment charge of 51.9millionforlonglivedassetsintheUSand51.9 million for long-lived assets in the US and 20.4 million in International markets for the year ended December 31, 2024 [438]. - The company evaluated its long-lived assets for impairment whenever events indicate that the carrying amount may not be fully recoverable [438]. - The company recorded non-cash impairment of long-lived assets totaling 72.3millionfortheyearendedDecember31,2024,comparedto72.3 million for the year ended December 31, 2024, compared to 107.9 million in 2023 and 133.1millionin2022[514].Thecompanyrecordedagainof133.1 million in 2022 [514]. - The company recorded a gain of 15.5 million from the sale of its 10% investment in Saudi Cinema Company LLC, which was sold for SAR 112.5 million (30.0million)onJanuary25,2023[561].CurrencyandMarketRisksThecompanyisexposedtofluctuationsinforeigncurrencyexchangerates,withahypothetical1030.0 million) on January 25, 2023 [561]. Currency and Market Risks - The company is exposed to fluctuations in foreign currency exchange rates, with a hypothetical 10% increase potentially impacting net income [417]. - A hypothetical 10% increase in foreign currency translation rates would increase the aggregate net loss of the company's International theatres by approximately 9.0 million for the year ended December 31, 2024 [427]. - The company experienced an aggregate net loss increase of approximately 10.9millionduetoahypothetical1010.9 million due to a hypothetical 10% increase in foreign currency translation rates for the year ended December 31, 2023 [427]. - The foreign currency translation rates increased by approximately 0.7% for the year ended December 31, 2024 compared to the previous year [428]. Internal Controls and Reporting - The company's internal control over financial reporting was deemed effective as of December 31, 2024, based on the COSO criteria [451]. - The company’s internal control over financial reporting has been audited by Ernst & Young LLP, confirming its effectiveness [434]. - The company’s management conducted an evaluation of the effectiveness of internal control over financial reporting as of December 31, 2024 [430]. - The company’s financial statements were audited and presented fairly in all material respects for the years ended December 31, 2024 and 2023 [433]. Stockholder Equity and Market Performance - The company’s total stockholders' deficit increased to 8.35 billion as of December 31, 2024 [470]. - The company issued 75,497,216 shares, raising 252.8millionduringthereportingperiod[470].Thecompanyscashburnratesarenotsustainablelongterm,necessitatingareturntopreCOVID19revenuelevels[477].Thecompanyanticipatesthatachievingsustainablenetpositivecashflowswillrequiresignificantrevenueincreases[477].PensionandEmployeeBenefitsFortheyearendedDecember31,2024,theCompanyexpectstocontribute252.8 million during the reporting period [470]. - The company’s cash burn rates are not sustainable long-term, necessitating a return to pre-COVID-19 revenue levels [477]. - The company anticipates that achieving sustainable net positive cash flows will require significant revenue increases [477]. Pension and Employee Benefits - For the year ended December 31, 2024, the Company expects to contribute 2.4 million to the U.S. pension plans [520]. - The aggregated projected benefit obligation for U.S. pension benefits at the end of 2024 was 73.8million,downfrom73.8 million, down from 79.3 million in 2023 [519]. - The Company’s net periodic benefit costs for the year ended December 31, 2024, were 1.8million,anincreasefrom1.8 million, an increase from 1.4 million in 2023 [522]. - The Company’s defined contribution plan expenses were 10.5million,10.5 million, 9.8 million, and 9.0millionfortheyearsendedDecember31,2024,2023,and2022,respectively[526].LeaseandOperatingCostsTotalleasecostsfortheyearendedDecember31,2024,were9.0 million for the years ended December 31, 2024, 2023, and 2022, respectively [526]. Lease and Operating Costs - Total lease costs for the year ended December 31, 2024, were 989.2 million, compared to 967.4millionin2023[550].TheweightedaverageremainingleasetermforoperatingleasesasofDecember31,2024,was8.1years,withadiscountrateof10.7967.4 million in 2023 [550]. - The weighted average remaining lease term for operating leases as of December 31, 2024, was 8.1 years, with a discount rate of 10.7% [550]. - The Company had signed additional operating lease agreements for six theatres with total lease payments of approximately 107.3 million, pending commencement [553]. - The Company recorded lease liabilities based on the present value of minimum lease payments, which include base rent and other fixed payments [511].